A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT02013219 · COMPLETED
Trial details
- NCT number
- NCT02013219
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-03
- Primary completion
- 2020-02-05
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.